EuroNanoMed 3

Call 2021

Topics

1. Regenerative medicine (TACR does not support)
2. Diagnostics
3. Targeted delivery systems
   

Participating countries

Belgium (FRS-FNRS), Bulgaria (BNSF), Czech Republic (TA CR), Egypt (ASRT), Estonia (ETAg), France (ANR), Israel (CSO-MOH), Italy (IMH), Latvia (SEDA/VIAA), Lithuania (RCL), Poland (NCBR), Romania (UEFISCDI), Slovakia (SAS), Spain (ISCIII; CDTI), Tchaj-wan (MOST), Turkey (TUBITAK)

General conditions for application

A consortium applying to this call will be required to include research group(s) from at least 2 of the 3 following categories, if eligible according to relevant national/regional funding organisations’ regulations for research funding^[1]:

• Academia (research teams working in universities, other higher education institutions or research institutes);
• Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of Medical Doctors is encouraged;
• Enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) will be encouraged.

Only transnational projects will be funded. Each consortium submitting a proposal will need to involve a minimum of 3 eligible and a maximum of 5 eligible partners from at least 3 different countries participating to the call (see list below) though no more than 2 eligible partners from the same country participating in the call will be accepted in one consortium.

Partners not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding organisation) may participate in transnational projects if they are able to secure their own funding. However, no more than one research group with own funding can be included in a consortium. The coordinator must be eligible to be funded by the participating funding organisations.

The maximum number of partners will possibly be increased from 5 to 7 (including eligible for funding and non-eligible for funding research groups) if partners from these participating countries, whose scientific community has been under-represented in past EuroNanoMed calls: Bulgaria, Czech Republic, Egypt, Estonia, Latvia, Lithuania, Romania, Slovakia, Taiwan and Turkey:

Please note! Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed funding organisation respective of the country/region from which applicants have applied. The applications are therefore subject to eligibility criteria of individual funding organisations.

Applicants are strongly advised to contact their relevant funding organisation contact person before submitting an application; please note that for some countries/regions it might be mandatory.

For more information see the Call text.

Partner search tools

Have a look at the European Nanomedicine Map: www.etp-nanomedicine.eu/about-nanomedicine/european-nanomedicine-map/

Or use any other H2020 NCP Partner-Search Tools here.

And use the EuroNanoMed partnering tool: www.euronanomed.net/partner-search/list-of-searches-and-offers/

TA CR Partenring Tool

Documents

Call text

Guidelines for applicants

Pre-proposal application form

Documents for Czech applicants are here in section “Dokumenty”. All documents proving the eligibility of the Czech applicant  must be send to TACR data box (ID: afth9xp) within the same deadline as the project pre-proposals.
Please fill in the subject line as: „Horizon2020 – EuroNanoMed 3 Call 2021 – prokázání způsobilosti – akronym projektu“.

Electronic submission system

Research project consortia who intend to submit a transnational proposal should register at https://ptoutline.eu/app/euronanomed2021, clicking the “to register” button and following the directions. Electronic proposal submission of proposals on the indicated website is mandatory.